Evidence map›Paper›PMID 35582438›Full record

ArticleCancer drug resistance (Alhambra, Calif.)2020

Pretreatment inflammatory indices predict Bevacizumab response in recurrent Glioma.

Alicia Martínez-González, Raquel Cabrera, Marta Lloret, Pedro C Lara

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer drug resistance (Alhambra, Calif.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Overcoming drug resistance in glioblastoma: new options in sight?Cancer drug resistance (Alhambra, Calif.) · 2021
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Alicia Martínez-GonzálezDepartment de Matemáticas, Universidad de Castilla-La Mancha, ETSI Industriales, Avda, Ciudad Real 13071, Spain.
Raquel CabreraOncología Radioterápica Hospital Universitario de Gran Canaria Dr Negrin, Barranco de la Ballena s/n, Las Palmas de Gran Canaria, Las Palmas 35010, Spain.
Marta LloretOncología Radioterápica Hospital Universitario de Gran Canaria Dr Negrin, Barranco de la Ballena s/n, Las Palmas de Gran Canaria, Las Palmas 35010, Spain.
Pedro C LaraFundación Canaria del Instituto Canario de Investigación del Cáncer, Avda de la Trinidad 61 Torre Agustín Arevalo 7 planta La Laguna, Santa Cruz de Tenerife 38204, Spain.
Universidad de Las Palmas de Gran Canaria · ESHospital Universitario de Gran Canaria Doctor Negrín · ESUniversity of Castilla-La Mancha · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bevacizumabinflammatory indiceslymphocytespredictive biomarkerRecurrent glioma

Identifiers

PMID35582438
PMCPMC8992487
OpenAlexW3048115441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.